Inflammation and epstein-barr virus infection are common features of myasthenia gravis thymus: possible roles in pathogenesis [0.03%]
炎症和eb病毒感染肌无力胸腺的常见特征：在发病机制中的可能作用
Paola Cavalcante,Lorenzo Maggi,Lara Colleoni et al.
Paola Cavalcante et al.
The thymus plays a major role in myasthenia gravis (MG). Our recent finding of a persistent Epstein-Barr (EBV) virus infection in some MG thymuses, combined with data showing that the thymus is in a proinflammatory state in most patients, s...
A systematic review of serum biomarkers anti-cyclic citrullinated Peptide and rheumatoid factor as tests for rheumatoid arthritis [0.03%]
抗环瓜氨酸肽和类风湿因子作为检测类风湿性关节炎的血清生物标志物的系统评价
Peter Taylor,Juliane Gartemann,Jeanie Hsieh et al.
Peter Taylor et al.
This systematic review assesses the current status of anti-cyclic citrullinated peptide (anti-CCP) and rheumatoid factor (RF) tests in the diagnosis and prognosis of rheumatoid arthritis (RA). We reviewed publications on tests and biomarker...
Long-term respiratory muscle endurance training in patients with myasthenia gravis: first results after four months of training [0.03%]
重症肌无力患者长期的呼吸肌耐力训练：四个月后的初步结果
Beate Rassler,Grit Marx,Stephanie Hallebach et al.
Beate Rassler et al.
Myasthenia gravis (MG) is characterized by reduced muscle endurance and is often accompanied by respiratory complications. Improvement of respiratory function is therefore an important objective in MG therapy. A previous study demonstrated ...
Fredrik Romi
Fredrik Romi
One half of cortical thymoma patients develop myasthenia gravis (MG), while 15% of MG patients have thymomas. MG is a neuromuscular junction disease caused in 85% of the cases by acetylcholine receptor (AChR) antibodies. Titin and ryanodine...
Matrix metalloproteinase-3 in myasthenia gravis compared to other neurological disorders and healthy controls [0.03%]
与其它神经性疾病及正常人对照的重症肌无力的基质金属蛋白酶-3检测
Steven P Luckman,Nils Erik Gilhus,Fredrik Romi
Steven P Luckman
MMP-3 is capable of degrading a variety of proteins, including agrin, which plays a critical role in neuromuscular signaling by controlling acetylcholine receptor clustering. High MMP-3 levels in a proportion of myasthenia gravis (MG) patie...
Headache associated with myasthenia gravis: the impact of mild ocular symptoms [0.03%]
重症肌无力相关性头痛及轻度眼肌型重症肌无力的影响
Yoshinori Nishimoto,Shigeaki Suzuki,Kimiaki Utsugisawa et al.
Yoshinori Nishimoto et al.
Myasthenia gravis (MG) patients visiting outpatient clinics frequently complain of headache. However, there have been few reports on the relation between chronic headache and myasthenia gravis (MG). We aimed to investigate whether MG sympto...
The effects of omega-3 Fatty acids on matrix metalloproteinase-9 production and cell migration in human immune cells: implications for multiple sclerosis [0.03%]
ω-3脂肪酸对人免疫细胞基质金属蛋白酶-9产生的影响及细胞迁移的作用：对多发性硬化症的意义
Lynne Shinto,Gail Marracci,Lauren Bumgarner et al.
Lynne Shinto et al.
In multiple sclerosis (MS), compromised blood-brain barrier (BBB) integrity contributes to inflammatory T cell migration into the central nervous system. Matrix metalloproteinase-9 (MMP-9) is associated with BBB disruption and subsequent T ...
Shigeaki Suzuki,Kimiaki Utsugisawa,Yuriko Nagane et al.
Shigeaki Suzuki et al.
Myasthenia gravis (MG) is caused by antibodies that react mainly with the acetylcholine receptor on the postsynaptic site of the neuromuscular junction. A wide range of clinical presentations and associated features allow MG to be classifie...
A Case of Thrombotic Thrombocytopenia Purpura Associated with Systemic Lupus Erythematosus: Diagnostic Utility of ADAMTS-13 Activity [0.03%]
与系统性红斑狼疮相关的血栓性血小板减少性紫癜一例及ADAMTS-13活性的诊断价值分析
Risa Yamada,Kazuhisa Nozawa,Takashi Yoshimine et al.
Risa Yamada et al.
Thrombotic thrombocytopenia purpura (TTP) caused by a deficiency in ADAMTS-13 activity is considered to involve a subset of thrombotic microangiopathy (TMA). Although concept of TTP is included under the umbrella of TMA, discrimination of T...
Case Reports
Autoimmune diseases. 2011:2011:483642. DOI:10.4061/2011/483642 2011
Multiple sclerosis [0.03%]
多发性硬化症
Sreeram Ramagopalan,David Dyment,Rachel Farrell et al.
Sreeram Ramagopalan et al.